Anti-SLC18B1 monoclonal antibody

Pre-made anti-SLC18B1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC18B1/SLC18B1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1658-Ab-1/ GM-Tg-hg-IP1658-Ab-2Anti-Human SLC18B1 monoclonal antibodyHuman
GM-Tg-rg-IP1658-Ab-1/ GM-Tg-rg-IP1658-Ab-2Anti-Rat SLC18B1 monoclonal antibodyRat
GM-Tg-mg-IP1658-Ab-1/ GM-Tg-mg-IP1658-Ab-2Anti-Mouse SLC18B1 monoclonal antibodyMouse
GM-Tg-cynog-IP1658-Ab-1/ GM-Tg-cynog-IP1658-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC18B1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1658-Ab-1/ GM-Tg-felg-IP1658-Ab-2Anti-Feline SLC18B1 monoclonal antibodyFeline
GM-Tg-cang-IP1658-Ab-1/ GM-Tg-cang-IP1658-Ab-2Anti-Canine SLC18B1 monoclonal antibodyCanine
GM-Tg-bovg-IP1658-Ab-1/ GM-Tg-bovg-IP1658-Ab-2Anti-Bovine SLC18B1 monoclonal antibodyBovine
GM-Tg-equg-IP1658-Ab-1/ GM-Tg-equg-IP1658-Ab-2Anti-Equine SLC18B1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1658-Ab-1/ GM-Tg-hg-IP1658-Ab-2; GM-Tg-rg-IP1658-Ab-1/ GM-Tg-rg-IP1658-Ab-2;
GM-Tg-mg-IP1658-Ab-1/ GM-Tg-mg-IP1658-Ab-2; GM-Tg-cynog-IP1658-Ab-1/ GM-Tg-cynog-IP1658-Ab-2;
GM-Tg-felg-IP1658-Ab-1/ GM-Tg-felg-IP1658-Ab-2; GM-Tg-cang-IP1658-Ab-1/ GM-Tg-cang-IP1658-Ab-2;
GM-Tg-bovg-IP1658-Ab-1/ GM-Tg-bovg-IP1658-Ab-2; GM-Tg-equg-IP1658-Ab-1/ GM-Tg-equg-IP1658-Ab-2
Products NameAnti-SLC18B1 monoclonal antibody
Formatmab
Target NameSLC18B1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC18B1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1658-Ag-1Recombinant multi-species S18B1/ SLC18B1/ C6orf192 protein
    ORF Viral VectorpGMLPm004899mouse Slc18b1 Lentivirus plasmid
    ORF Viral VectorvGMLPm004899mouse Slc18b1 Lentivirus particle


    Target information

    Target IDGM-IP1658
    Target NameSLC18B1
    Gene ID116843,76306,309570,708518,611318,101097483,529052,100073127
    Gene Symbol and Synonyms1110021L09Rik,C6orf192,C9H6orf192,dJ55C23.6,RGD1306962,SLC18B1,VPAT
    Uniprot AccessionQ6NT16,D4A9K4
    Uniprot Entry NameS18B1_HUMAN,D4A9K4_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000146409
    Target ClassificationN/A

    The target: SLC18B1, gene name: SLC18B1, also named as C6orf192, dJ55C23.6. This gene encodes a protein, which has high sequence similarity to rat, xenopus and zebrafish proteins. The protein function is unknown. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.